 Inhibition metabolism atrial natriuretic factor diuresis natriuresis chronic heart failure Atrial natriuretic factor ANF peptide hormone heart vivo endopeptidase atriopeptidase novel atriopeptidase inhibitor plasma levels ANF animals normal volunteers diuresis natriuresis study effects UK patients mild heart failure intravenous infusion min placebo-controlled cross-over study patients stable NYHA Class chronic heart failure atriopeptidase inhibitor side effects Mean baseline plasma ANF pg/mL normal UK administration Plasma ANF placebo marked diuresis UK Urinary sodium excretion significant rise potassium excretion increase plasma active renin concentration study period Noninvasive hemodynamic monitoring significant changes heart rate systemic arterial blood pressure echocardiographic ventricular dimensions invasive measurements Swan-Ganz catheter falls mean right atrial pulmonary artery wedge pressures UK change cardiac output inhibition endopeptidase UK results significant elevation plasma ANF associated diuresis natriuresis venodilatation compound patients mild chronic heart failure